Literature DB >> 28887146

Analysing the effect of multiple sclerosis on vitamin D related biochemical markers of bone remodelling.

Malachi J McKenna1, Barbara Murray2, Roisin Lonergan3, Ricardo Segurado4, Niall Tubridy5, Mark T Kilbane2.   

Abstract

The Irish population is at risk of vitamin D deficiency during the winter months, but the secular trend over the past 40 years is for marked improvement. Multiple sclerosis (MS) is common in Ireland with a latitudinal pattern favouring highest incidence in northern regions; MS is linked strongly with vitamin D status as a causal factor. We sought firstly to study the relationship between vitamin D status and vitamin D-related bone biochemistry, and secondly to evaluate if MS had an independent effect on vitamin D related markers of bone remodelling. Using a case-control design of 165 pairs (MS patient and matched control) residing in three different geographic regions during winter months, we measured serum 25-hydroxyvitamin D (25OHD), parathyroid hormone (PTH), C-terminal telopeptide of type I collagen (CTX) and total procollagen type I amino-terminal propeptide (PINP). Given the paired case-control design, associations were explored using mixed-effects linear regression analysis with the patient-control pair as a random effect and after log transformation of 25OHD. A two-way interaction effect was tested for vitamin D status (25OHD <30nmol/L) and the presence of MS on PTH, CTX, and PINP. In the total group, just over one-third (34.5%) had 25OHD <30nmol/L. PTH was elevated in 7.6%. CTX was not elevated in any case, and PINP was elevated in 4.5%. On mixed-effects linear regression analysis after adjusting for confounders (age, sex, renal function, and serum albumin), we demonstrated the principal determinant of 25OHD was geographical location (p<0.001), of PTH was 25OHD (p<0.001), of CTX was PTH (p<0.001), and of PINP was PTH (p<0.001). MS did not have an independent effect on PTH (p=0.921), CTX (p=0.912), or PINP (p=0.495). As regards an interaction effect, the presence of MS and 25OHD <30nmol/L was not significant but tended towards having lower PTH (p=0.207). In conclusion, in Ireland in winter only a minority had any abnormality in the secondary indices of vitamin D deficiency, and MS had no independent effect on parathyroid status or bone remodelling activity.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone turnover; Multiple sclerosis; Vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28887146     DOI: 10.1016/j.jsbmb.2017.09.002

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  2 in total

1.  Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.

Authors:  Mark Simon Stein; Gregory John Ward; Helmut Butzkueven; Trevor John Kilpatrick; Leonard Charles Harrison
Journal:  Mol Med       Date:  2018-05-30       Impact factor: 6.354

2.  Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)2D, but No Difference in Ratio of 25(OH)D/24,25(OH)2D and FGF23 Concentrations.

Authors:  Mariska C Vlot; Laura Boekel; Jolijn Kragt; Joep Killestein; Barbara M van Amerongen; Robert de Jonge; Martin den Heijer; Annemieke C Heijboer
Journal:  Nutrients       Date:  2019-11-15       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.